COMT inhibition in Parkinson’s Disease Learning Zone

eLearning modules

Read time: 10 mins

Understand why patients usually require higher and more frequent dosing of levodopa or the addition of other therapies such as COMT inhibitors as PD progresses.

Find out when levodopa therapy should be initiated and discover how catechol-O-methyltransferase (COMT) inhibitors may be used in conjunction with levodopa to help control motor symptoms in patients with Parkinson’s disease (PD). In these interactive eLearning modules, the expert faculty address important questions in the field of PD research, providing insight into the steps that can be taken to optimise patient outcomes.

Levodopa is considered the gold standard of treatment in Parkinson’s disease, but there is still some debate as to when levodopa therapy should be initiated.

Click here to register now

Welcome:

Updates in your area
of interest

Articles your peers
are looking at

Bookmarks
saved

Days to your
next event